The United Kingdom Prospective Diabetes Study demonstrated the advantages of the early addition of insulin to conventional diet-plus-OAD treatment if the fasting plasma glucose (FPG) remained > 108 mg/dL despite maximal doses of sulfonylurea [31]. The gene discussed is INS; the disease is diabetes mellitus.